Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Controlled & Modified Release
Film Formers & Plasticizers
Solubilizers
Emulsifying Agents
Thickeners and Stabilizers
Parenteral
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Fenoldopam Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fenoldopam Mesylate, including repackagers and relabelers. The FDA regulates Fenoldopam Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fenoldopam Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fenoldopam Mesylate supplier is an individual or a company that provides Fenoldopam Mesylate active pharmaceutical ingredient (API) or Fenoldopam Mesylate finished formulations upon request. The Fenoldopam Mesylate suppliers may include Fenoldopam Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Fenoldopam Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fenoldopam Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Fenoldopam Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Fenoldopam Mesylate DMFs exist exist since differing nations have different regulations, such as Fenoldopam Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fenoldopam Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Fenoldopam Mesylate USDMF includes data on Fenoldopam Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fenoldopam Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fenoldopam Mesylate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fenoldopam Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fenoldopam Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fenoldopam Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fenoldopam Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fenoldopam Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fenoldopam Mesylate suppliers with NDC on PharmaCompass.
Fenoldopam Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fenoldopam Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fenoldopam Mesylate GMP manufacturer or Fenoldopam Mesylate GMP API supplier for your needs.
A Fenoldopam Mesylate CoA (Certificate of Analysis) is a formal document that attests to Fenoldopam Mesylate's compliance with Fenoldopam Mesylate specifications and serves as a tool for batch-level quality control.
Fenoldopam Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Fenoldopam Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fenoldopam Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Fenoldopam Mesylate EP), Fenoldopam Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fenoldopam Mesylate USP).
LOOKING FOR A SUPPLIER?
